JPY4,254.00
0.33% today
Tokyo, Mar 13, 07:14 am CET
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Eisai Stock price

JPY4,257.00
-162.00 3.67% 1M
-1,572.00 26.97% 6M
-72.00 1.66% YTD
-2,231.00 34.39% 1Y
-1,352.00 24.10% 3Y
-2,609.00 38.00% 5Y
-2,894.00 40.47% 10Y
Tokyo, Closing price Thu, Mar 13 2025
-11.00 0.26%
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Key metrics

Market capitalization JPY1.20t
Enterprise Value JPY1.16t
P/E (TTM) P/E ratio 20.64
EV/FCF (TTM) EV/FCF 75.04
EV/Sales (TTM) EV/Sales 1.46
P/S ratio (TTM) P/S ratio 1.52
P/B ratio (TTM) P/B ratio 1.38
Dividend yield 3.75%
Last dividend (FY25) JPY160.00
Revenue growth (TTM) Revenue growth 5.63%
Revenue (TTM) Revenue JPY791.66b
EBIT (operating result TTM) EBIT JPY52.62b
Free Cash Flow (TTM) Free Cash Flow JPY15.42b
Cash position JPY291.26b
EPS (TTM) EPS JPY206.83
P/E forward 26.00
P/S forward 1.56
EV/Sales forward 1.49
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,808 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Eisai forecast:

4x Buy
29%
8x Hold
57%
2x Sell
14%

Analyst Opinions

14 Analysts have issued a Eisai forecast:

Buy
29%
Hold
57%
Sell
14%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
791,660 791,660
6% 6%
100%
- Direct Costs 164,310 164,310
4% 4%
21%
627,350 627,350
6% 6%
79%
- Selling and Administrative Expenses 364,802 364,802
15% 15%
46%
- Research and Development Expense 169,870 169,870
4% 4%
21%
92,678 92,678
6% 6%
12%
- Depreciation and Amortization 40,057 40,057
1% 1%
5%
EBIT (Operating Income) EBIT 52,621 52,621
11% 11%
7%
Net Profit 58,793 58,793
29% 29%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today